Nataskia Lampe

Nataskia Lampe is an experienced professional in the field of regulatory affairs, currently serving as Vice President of Global Regulatory Affairs at ACELYRIN, INC. Previous roles include Executive Director of Regulatory Affairs for Cell and Gene Therapy at Vertex Pharmaceuticals and Vice President, Head of Regulatory Affairs at Pieris Pharmaceuticals. Nataskia has also held positions at AbbVie, where responsibilities included Asset Strategy Leader for Neuroscience, Fibrosis, and Virology, as well as Director of Global Regulatory Strategy in Oncology. Early in the career, Nataskia served as Associate Director of North American Regulatory Affairs at Lung Rx, Inc. Academic credentials include a Master of Science in Biomedical Chemistry from Jefferson Health and further education at Walden University from 2008 to 2014.